$0.09
0.00 (-2.30%)
VVOS News2 articles
Vivos Therapeutics Stock Jumps 36% on Debt-to-Equity Swap to Meet Nasdaq Rule
Vivos Therapeutics shares surged 36% after a $4.5 million debt-to-equity swap with Streeterville Capital to address Nasdaq compliance, though the deal depends on new equity financing.
VivoSim Labs Soars on $5M Lilly Milestone, But Revenue Base Remains Tiny
VivoSim Labs hit a $5M milestone from Eli Lilly, but its revenue base of $131K and a 500% growth target highlight ongoing cash challenges.